Literature DB >> 6686962

A comparison of the content and immunohistochemical patterns of CEA-like activity in human colorectal tumours and nude mouse xenografts.

J C Lewis, P A Smith, P A Keep, G M Boxer.   

Abstract

The immunohistochemical pattern of CEA-like material was examined in sections of five human colonic tumour xenograft lines in nude mice and in the primary tumours from which these lines were derived. Conventional tissue sections were stained by a PAP immunoperoxidase technique, using affinity purified goat anti-CEA as the primary reagent. Normal human and nude mouse tissues were also examined. Saline extracts were made from three of the human tumours and from examples of the respective xenograft lines. The CEA content of extracts was determined by radioimmunoassay. The pattern of CEA-like material was similar in primary tumours and xenografts, but in 3/5 xenograft lines the intensity of specific staining was reduced when compared to that of the respective primary tumour. The three xenograft lines from which extracts were made contained mean values of 22%, 63% and 68% of the CEA activity found in the respective primary tumours, and the data suggested that reduced immunoperoxidase stain intensity seen in some xenografts resulted from the presence of far less antigen than in the corresponding primary tumour. We suggest that some xenograft lines represent subpopulations of cells in the primary tumour which produce less CEA than those of the primary tumour sample examined, although histologically no differences can be identified. No CEA-like activity was detected in normal nude mouse tissues.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6686962     DOI: 10.1016/s0232-1513(83)80010-3

Source DB:  PubMed          Journal:  Exp Pathol        ISSN: 0232-1513


  8 in total

1.  Relationship between tumour size and uptake of radiolabelled anti-CEA in a colon tumour xenograft.

Authors:  R B Pedley; J Boden; P A Keep; P J Harwood; A J Green; G T Rogers
Journal:  Eur J Nucl Med       Date:  1987

2.  Suppression of well-established tumour xenografts by a hybrid-hybrid monoclonal antibody and vinblastine.

Authors:  W Smith; V A Gore; D R Brandon; D N Lynch; S A Cranstone; J R Corvalan
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

3.  Increased therapeutic effect of vinca alkaloids targeted to tumour by a hybrid-hybrid monoclonal antibody.

Authors:  J R Corvalan; W Smith; V A Gore; D R Brandon; P J Ryde
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

4.  Specific in vitro and in vivo drug localisation to tumour cells using a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids.

Authors:  J R Corvalan; W Smith; V A Gore; D R Brandon
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

5.  Prolonged localisation of a monoclonal antibody against CEA in a human colon tumour xenograft.

Authors:  P J Harwood; R B Pedley; J Boden; G Rawlins; C R Pentycross; G T Rogers; K D Bagshawe
Journal:  Br J Cancer       Date:  1985-11       Impact factor: 7.640

6.  The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model.

Authors:  R B Pedley; J A Boden; R W Boden; A Green; G M Boxer; K D Bagshawe
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

Review 7.  The First Bagshawe lecture. Towards generating cytotoxic agents at cancer sites.

Authors:  K D Bagshawe
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

8.  Preliminary observations on the microdistribution of labelled antibodies in human colonic adenocarcinoma xenografts: relevance to microdosimetry.

Authors:  R B Pedley; G M Boxer; J A Boden; P J Southall; R H Begent; K D Bagshawe; J Humm; F Searle
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.